The Kaohsiung Journal of Medical Sciences 2022

5 papers
In 2022, The Kaohsiung Journal of Medical Sciences featured research primarily focused on molecular oncology and the regulatory mechanisms of non-coding RNAs. A significant portion of the published work investigated the signaling pathways driving cancer progression, including studies on the ZNF521/EBF1 axis in gastric cancer and the role of LncRNA HCP5 in osteosarcoma. Research also addressed triple-negative breast cancer, specifically examining the PI3K/AKT/mTOR signaling pathway. Beyond oncology, the journal explored microvascular complications in diabetic retinopathy, highlighting the influence of the LncRNA SNHG1/miR-340-5p/PIK3CA axis on endothelial cell proliferation and angiogenesis. Clinical contributions included a narrative review of diagnostic and therapeutic advancements for renal epithelioid angiomyolipoma. Prolific authors contributing to the year’s discourse included Fan Wu, Hong Yi, and Jian Liu, among others. Collectively, the 2022 edition emphasized the intersection of molecular biology and clinical pathology, focusing on the genetic axes that govern cell migration, invasion, and vascular health.

Top Research Directions

The 10 research directions with The Kaohsiung Journal of Medical Sciences 2022 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Bidirectional Functional Validation of Gene Expression in Disease Models120.0%
2Generalizability of In Vitro Findings to In Vivo Systems120.0%
3How Chronic Inflammation Triggers Malignant Transformation and Progression120.0%
4Measuring Transcriptional Activity with Dual Luciferase Assays120.0%
5Molecular Drivers of Cancer Cell Migration and Metastasis120.0%
6Molecular Drivers of Tumor Progression and Malignancy120.0%
7Multi-Modal Triangulation for Complex Clinical Diagnostics120.0%
8Prospective Validation for Clinical Predictive Models120.0%
9Systematic Evidence Mapping and Scoping Reviews120.0%
10Validating Direct Transcription Factor Promoter Interactions120.0%

Download all directions as CSV

Institutions

Institutions credited by The Kaohsiung Journal of Medical Sciences 2022 papers: a paper credits every institution named in its affiliations, once. 2 institutions share 2 credited papers.

#InstitutionPapersShare
1Lanzhou University 150.0%
2Nanjing Medical University 150.0%

Download all institutions as CSV

About this data

Papers. The Kaohsiung Journal of Medical Sciences 2022 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 5 papers (40.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Kaohsiung Journal of Medical Sciences 2022”, https://lacuna.tiptreesystems.com/venue/the-kaohsiung-journal-of-medical-sciences/2022.

Impactful Papers

Papers from The Kaohsiung Journal of Medical Sciences 2022 that shaped research clusters.

Influential

Papers

Title
Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: A narrative review
Corrigendum to “Protective effect of <scp>hsa‐miR</scp>‐570‐3p targeting <scp>CD274</scp> on triple negative breast cancer by blocking <scp>PI3K</scp>/<scp>AKT</scp>/<scp>mTOR</scp> signaling pathway”
Long noncoding <scp>RNA HCP5</scp> promotes osteosarcoma cell proliferation, invasion, and migration via the <scp>miR‐29b‐3p‐LOXL2</scp> axis
<scp>LncRNA SNHG1</scp> targets <scp>miR</scp>‐340‐5p/<scp>PIK3CA</scp> axis to regulate microvascular endothelial cell proliferation, migration, and angiogenesis in <scp>DR</scp>
<scp>ZNF521</scp>/<scp>EBF1</scp> axis regulates <scp>AKR1B1</scp> to promote the proliferation, migration, and invasion of gastric cancer cells